<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201011085136N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2011-05-10</date_registration>
      <primary_sponsor>Isfahan Cardivascular Research Center</primary_sponsor>
      <public_title>Cardiac Rehabilitation in Heart Disease Patient</public_title>
      <acronym>Cardiac Rehabilitation</acronym>
      <scientific_title>The effect of a cardiac rehabilitation program on systolic, diastolic function, left ventricle mass and functional capacity in patient with myocardial infarction</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2010-11-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/5464</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Myocardial Infarction.</hc_freetext>
      <i_freetext>Intervention 1: Rehabilitation program for 8-week course of aerobic exercise (three 60-minute sessions per week). Aerobic exercise including stretching exercises for warm-up, aerobic exercises on treadmill ergo meter, stepper and kayak equipment in 60-85% of maximum heart rate of each patient. Exercises will be prescribed for each participant individually, based on his physiological abilities. Intervention 2: 2 month detraining for control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Basati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>jahad 16 A., jahad, Isalam abad .Kermanshah</address>
        <city>Islam Abad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6761957655</zip>
        <telephone>+98 83 2524 1887</telephone>
        <email>basatifatemeh@yahoo.com: fatemeh.basati1987@gmail.com</email>
        <affiliation>Isfahan Univercity</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Basati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jahad 16 A, Jahad, Islam Abad Gharb, Kermanshah</address>
        <city>Islam Abad Gharb</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6761957655</zip>
        <telephone>+98 83 2524 1887</telephone>
        <email>basatifatemeh@yahoo.com</email>
        <affiliation>Isfahan university</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:   &#13;
Patients with ST elevation myocardial infarction, history of CABG and PTCA, have ability to present in cardiac rehabilitation program, not having any physical exercise out of cardiac rehabilitation program, cardiac rehabilitation start 2 month after CABG and 1 month after PTCA&#13;
Exclusion criteria:&#13;
Absence more than five sessions in rehabilitation programs, re-infarction, extra physical activity.</inclusion_criteria>
      <agemin>37 years</agemin>
      <agemax>67 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I23</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Myocardial Infarction specified as Acute or with a stated duration of 4 weeks (28 days) or less from onset</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Rehabilitation program for 8-week course of aerobic exercise (three 60-minute sessions per week). Aerobic exercise including stretching exercises for warm-up, aerobic exercises on treadmill ergo meter, stepper and kayak equipment in 60-85% of maximum heart rate of each patient. Exercises will be prescribed for each participant individually, based on his physiological abilities.</i_keyword>
      <i_keyword>2 month detraining for control group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Left Ventricular End Diastolic Dimention. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiography.</prim_outcome>
      <prim_outcome>Left Ventricular End Systolic Dimention. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.</prim_outcome>
      <prim_outcome>Left Ventricular End Systolic Volume. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.</prim_outcome>
      <prim_outcome>Left Ventricular End Diastolic Volume. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.</prim_outcome>
      <prim_outcome>Ejection Fraction. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.</prim_outcome>
      <prim_outcome>Stroke Volume. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.</prim_outcome>
      <prim_outcome>E velocity. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.</prim_outcome>
      <prim_outcome>A velocity. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.</prim_outcome>
      <prim_outcome>E/A ratio. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.</prim_outcome>
      <prim_outcome>Deceleration time. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Left ventricle mass. Timepoint: Before Intervention and 2 Month After Intervention. Method of measurement: 2 Dimentional Echocardiography.</sec_outcome>
      <sec_outcome>Blood Pressure. Timepoint: Before Intervention and 2 Month After Intervention. Method of measurement: Sphyngomanometer.</sec_outcome>
      <sec_outcome>Functional Capacity. Timepoint: Before Intervention and 2 Month After Intervention. Method of measurement: Naghoutan Protocol.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Isfahan Cardivascular Research Center</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2010-08-20</approval_date>
        <contact_name>Cardiovascular Research Center ethics Committee</contact_name>
        <contact_address>Cardiovascular Research Center, Khorram av., Jomhori Eslami Sq., Isfahan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
